Педиатрическая фармакология (Jun 2011)

MUCOPOLYSACCHARIDOSIS TYPE II

  • N.D. Vashakmadze,
  • L.S. Namazova-Baranova,
  • A.K. Gevorkyan,
  • L.M. Kuzenkova,
  • A.D. Khristochevskiy,
  • L.M. Vysotskaya,
  • A.S. Dadashev

Journal volume & issue
Vol. 8, no. 3
pp. 66 – 68

Abstract

Read online

Article is devoted to one of the orphan diseases — mucopolysaccharidosis (MPS), which is the result of any lysosomal enzyme deficiency (which determines the type of illness). The most common is the MPS type II (Hunter syndrome), developing as a result of deficiency of the enzyme alpha-L-iduronosulphatsulphataze. The authors are observing the largest group of children with this pathology in the Russian population — 40 patients. On the example of their own clinical cases the only existing on the date the pathogenetic treatment is provided — replacement therapy with idursulphase that significantly improves the disease prognosis.Key words: MPS, types, Hunter syndrome, clinical course, diagnosis, treatment, prognosis, children.